News Image

MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025

Provided By GlobeNewswire

Last update: Apr 15, 2025

LA JOLLA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announces that their CEO, Yuichi Iwaki, MD, Ph.D., and CBO, David H. Crean, Ph.D., will be participating in investor meetings at D. Boral Capital’s, Inaugural DBC Conference on May 14, 2025 at the Plaza Hotel, New York City. The conference will bring together public and private executives with institutional investors, high-net worth individuals, and corporate clients from various sectors including Healthcare & Life Sciences. Drs. Iwaki and Crean will be discussing MediciNova’s leading programs in neurologic and metabologic disorders. For more information about participation in the DBC Conference, visit https://dboralcapital.com/conference.

Read more at globenewswire.com

MEDICINOVA INC

NASDAQ:MNOV (7/25/2025, 8:07:40 PM)

After market: 1.5 +0.04 (+2.74%)

1.46

+0.22 (+17.74%)



Find more stocks in the Stock Screener

Follow ChartMill for more